AGP Picks
View all

Competent cells market seen reaching $5.59 billion by 2030

5 hours ago
Competent cells market seen reaching $5.59 billion by 2030
By AI, Created 18:30 UTC, Nov 19, 2026, AGP -

The global competent cells market is projected to grow from $3.4 billion in 2026 to $5.59 billion by 2030 as gene editing, synthetic biology and biopharmaceutical R&D expand. North America led the market in 2025, while Asia-Pacific is expected to grow fastest over the forecast period.

Why it matters: - Competent cells are a core tool for cloning and genetic transformation work in molecular biology. - The market’s growth signals rising demand for research inputs used in gene editing, synthetic biology and drug development. - The expansion also reflects broader biotech investment and more commercialized molecular biology reagents.

What happened: - The Business Research Company published its Competent Cells Global Market Report 2026, covering market size, trends and a forecast through 2035. - The report puts the market at $3 billion in 2025 and $3.4 billion in 2026. - The report forecasts the market will reach $5.59 billion by 2030. - The report says North America held the largest market share in 2025. - The report says Asia-Pacific is expected to grow faster than other regions during the forecast period.

The details: - The report ties recent growth to expanded molecular biology research, heavy use of E. coli cloning systems, more academic life science work, standardized competent cell products and more biotech laboratories. - The report says future growth will be driven by broader adoption of gene editing, rising synthetic biology investment, expansion of pharmaceutical R&D pipelines, stronger demand for high-throughput cloning tools and better commercialization of molecular biology reagents. - The report identifies improving transformation efficiency, higher demand for high-performance cloning strains, wider synthetic biology use, growth in ready-to-use competent cell kits and a stronger focus on reproducibility as key trends. - Competent cells are bacterial cells treated to take up foreign DNA through transformation. - Competent cells are used in cloning and genetic transformation experiments to introduce new genetic material into bacterial hosts. - The report says the expanding biopharmaceutical industry is a major growth driver. - Competent cells support genetic engineering, gene cloning and protein expression in biopharmaceutical workflows. - Competent cells help produce recombinant proteins, therapeutic enzymes and other biologics used in drug discovery and manufacturing. - In January 2025, the BioIndustry Association reported that the UK biotech sector attracted £3.5 billion, or about $4.4 billion, in investment in 2024. - That total was up 94% from the prior year.

Between the lines: - The forecast suggests competent cells are becoming more important as life sciences research shifts toward faster, more reproducible and higher-throughput workflows. - Strong biotech funding and pharmaceutical pipeline growth are likely to keep demand elevated for core lab reagents rather than only finished drugs. - North America’s lead reflects its concentration of biotechnology and molecular biology research, while Asia-Pacific’s faster growth points to widening global demand.

What's next: - The report expects continued adoption of gene editing and synthetic biology tools to support market growth through 2030. - Demand is likely to rise for ready-to-use kits and high-performance strains as labs seek speed and reproducibility. - The broader market outlook remains tied to biopharmaceutical R&D spending and commercialization of molecular biology products.

The bottom line: - Competent cells are moving from a niche lab input to a growing enabling market for biotech, genomics and drug discovery.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

Technology News UK

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Technology News UK

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.